CTC
Dashboard
Interface
Vaccinations
Add Vaccination
All Vaccinations
Packages
Add Package
All Packages
Blogs
Add Blog
All Blogs
Section Content
Add Section Item
All Section Items
Contacts
All Contacts
Settings
Home Page Settings
Contact Us Settings
About Page Settings
Profile Settings
Pages
Add Page
All Pages
3+
Alerts Center
December 12, 2019
A new monthly report is ready to download!
December 7, 2019
$290.29 has been deposited into your account!
December 2, 2019
Spending Alert: We've noticed unusually high spending for your account.
Show All Alerts
7
Message Center
Hi there! I am wondering if you can help me with a problem I've been having.
Emily Fowler · 58m
I have the photos that you ordered last month, how would you like them sent to you?
Jae Chun · 1d
Last month's report looks great, I am very happy with the progress so far, keep up the good work!
Morgan Alvarez · 2d
Am I a good boy? The reason I ask is because someone told me that people say this to all dogs, even if they aren't good...
Chicken the Dog · 2w
Read More Messages
Admin
Profile
Settings
Activity Log
Logout
Edit Vaccination
Name
Description
The shingles vaccine (Shingrix) protects against herpes zoster, a painful rash caused by reactivation of the chickenpox virus. Recommended by UK JCVI for eligible older adults and immunocompromised individuals.
Price
Currency
Dose
Age From
Age To
Vaccination Link
Additional Details
Timing
Effectiveness
Duration
Additional Notes
Timing Note
Shingrix is a two-dose vaccine. NHS offers it routinely from age 65; available privately for those aged 50 and over and for immunocompromised adults aged 18+.
Effectiveness Note
It has been demonstrated in clinical studies that the shingles vaccine prevents shingles and post-herpetic neuralgia in more than 90 percent. The general coverage of high levels is seen in all age groups, including adults aged 70 and above. The protection lasts no less than 10 years after vaccination, and further research is pointing towards long-term immunity.
Duration Note
The Shingles vaccine is recommended for adults over the age of 50, as they are more likely to develop Shingles.
Risk Information
High Risk Areas (one per line)
Not travel-related – shingles risk increases with age and immunosuppression Risk of reactivation exists worldwide for anyone who has had chickenpox
Traveller Risk Factors (one per line)
Adults aged 50 and over Immunocompromised individuals (from age 18) Previous chickenpox infection People with stress, illness, or weakened immunity
Protection Information
Protection Title
Protection Description
The shingles vaccine induces a strong antibody and a cellular immune response against the varicella-zoster virus in the immune system. This immunity much lessens the chances of getting shingles, as well as decreases the chances of getting permanent nerve discomfort in case of an infection. Vaccination is a good, long-term prevention of one of the most frequent viral complications of the elderly population.
Media
Image
Drag & drop an image here or click to select
Update
Back
Ready to Leave?
×
Select "Logout" below if you are ready to end your current session.
